£595.00

It has never been this cheap. We have no record of a lower price.

£595 today · cheaper than every other day in the last 3 months

Prostate Cancer Therapeutics Outlook in Japan (2016-2021)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 44 days · 44 data points (no recent data)

Historical
Generating forecast…
£595.00 £565.25 £577.15 £589.05 £600.95 £612.85 £624.75 11 August 2026 21 August 2026 01 September 2026 12 September 2026 23 September 2026
View at Amazon ↗

Price data last checked 47 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 44 days • 1 price levels

Days at Price
44 days 0 11 22 33 44 £595 Days at Price

Price Analysis

Most common price: £595 (44 days, 100.0%)

Price range: £595 - £595

Price levels: 1 different prices over 44 days

Description

This econometric study provides a detailed outlook for prostate cancer therapeutics in Japan from 2016 to 2021. The report focuses on latent demand, also known as potential industry earnings (P.I.E.), across various prefectures and cities. By providing estimates in millions of U.S. dollars for approximately 1,000 cities, this statistical analysis offers a foundation for developing effective distribution and sales force strategies. Using econometric models to project fundamental economic dynamics within specific Japanese regions, the study identifies potential market opportunities. This data-driven approach helps professionals understand the economic landscape of the prostate cancer therapeutic market throughout the specified period.

Key Features

Provides latent demand estimates for prostate cancer therapeutics across approximately 1,000 cities in Japan.

Includes potential industry earnings (P.I.E.) expressed in millions of U.S. dollars for regional analysis.

Utilizes econometric models to project fundamental economic dynamics within each prefecture and city.

Supports the development of distribution and sales force strategies through detailed geographic data.

Covers the specific outlook period from 2016 through 2021 for the Japanese market.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
22 September 2015
Listed Since
14 December 2016

Similar Products You Might Like

Prostate Cancer Therapeutics in Africa 2013-2018 Outlook
98% match

Prostate Cancer Therapeutics in Africa 2013-2018 Outlook

£325.00 03 Sep 2026
World Outlook for Prostate Cancer Treatments 2025-2030
98% match

World Outlook for Prostate Cancer Treatments 2025-2030

Price unavailable
Hormone Therapy for Prostate Cancer Outlook 2023-2028
98% match

Hormone Therapy for Prostate Cancer Outlook 2023-2028

£520.00 05 Nov 2026
Hormone Therapy for Prostate Cancer Outlook in India 2023-2028
98% match

Hormone Therapy for Prostate Cancer Outlook in India 2023-2028

£515.00 03 Nov 2026
Prostate Cancer Nuclear Medicine Diagnostics India Outlook
98% match

Prostate Cancer Nuclear Medicine Diagnostics India Outlook

£515.00 30 Oct 2026
World Outlook for Prostate Cancer Treatments 2025-2030
98% match

World Outlook for Prostate Cancer Treatments 2025-2030

Price unavailable
Prostate Cancer Nuclear Medicine Diagnostics Outlook 2023-2028
98% match

Prostate Cancer Nuclear Medicine Diagnostics Outlook 2023-2028

£520.00 28 Oct 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan
98% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan

£495.00 05 Nov 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China
97% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China

£495.00 31 Oct 2026
Bladder Cancer Therapeutics Outlook Japan 2016-2021
97% match

Bladder Cancer Therapeutics Outlook Japan 2016-2021

£595.00 28 Aug 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan
97% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan

£495.00 29 Oct 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 02 Nov 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China
97% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in Greater China

£595.00 27 Oct 2026
US Cancer Supportive Care Outlook 2023-2028 Study Report
97% match

US Cancer Supportive Care Outlook 2023-2028 Study Report

£520.00 07 Nov 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China
97% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China

£495.00 05 Nov 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
97% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 31 Oct 2026
World Outlook: Hormone Therapy for Prostate Cancer 2025-2030
97% match

World Outlook: Hormone Therapy for Prostate Cancer 2025-2030

Price unavailable
The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States
97% match

The 2016-2021 Outlook for Pancreatic Cancer Drugs in the United States

£595.00 08 Nov 2026
India Cancer Supportive Care Drugs Outlook 2023-2028
97% match

India Cancer Supportive Care Drugs Outlook 2023-2028

£515.00 06 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 30 Sep 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 04 Nov 2026
Cancer Supportive Care Drugs Outlook 2023-2028 Report
97% match

Cancer Supportive Care Drugs Outlook 2023-2028 Report

£520.00 06 Nov 2026
2023-2028 US Cancer Screening Outlook - Market Study
97% match

2023-2028 US Cancer Screening Outlook - Market Study

£520.00 05 Nov 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 30 Sep 2026